SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic ...
A recent study explores inflammatory profiles in low-risk MDS, revealing distinct patient categories and implications for ...
New BIDMC study on COVID-19 reveals persistent immune activation in patients who developed long COVID, which could help identify new paths to treatment.
2d
Chronic inflammation may cause long COVID — and could be the secret to treatment, new study says
Five years after the start of the pandemic, a group of researchers from Beth Israel Deaconess Medical Center is one step ...
Individuals with psychiatric disorders exhibiting seemingly similar symptoms often respond very differently to the same treatment, suggesting that distinct biological processes are at work beneath the ...
Microglial activity appears to determine when amyloid becomes biologically significant, reshaping how clinicians interpret ...
Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...
Ocular immunology investigates the complex interplay between molecular mediators and immune cells responsible for maintaining ocular immune privilege, as ...
Scientists have identified a gut microbe molecule, trimethylamine (TMA), that shows promise in controlling blood sugar and ...
The molecule counteracts damage caused by high-fat diets and even protects mice from sepsis. Since IRAK4 is a known drug target, this pathway could inspire new diabetes therapies. The study highlights ...
Sen-Jam Pharmaceutical, a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics for inflammation-driven conditions, today announced the appointment of Rute Fernandes as ...
The field of dermatology has witnessed remarkable progress in the prevention and treatment of skin diseases over the past ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback